T. Klumpp

发表

Single‐donor platelets reduce the risk of septic platelet transfusion reactions

J. Herman, T. Klumpp, 2002, Transfusion.

Providing personalized prognostic information for adult leukemia survivors.

Alan M. Miller, B. Storer, B. George, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease.

J. Klein, M. Horowitz, J. Wingard, 2011, Blood.

A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR.

J. Vose, J. Winter, P. Hari, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Antibody-mediated neutropenia following bone marrow transplantation

T. Klumpp, 1993, International journal of clinical & laboratory research.

Acquired uniparental disomy in chromosome 6p as a feature of relapse after T-cell replete haploidentical hematopoietic stem cell transplantation using cyclophosphamide tolerization

U. Martinez-outschoorn, N. Flomenberg, M. Kasner, 2017, Bone Marrow Transplantation.

Spontaneous graft versus host disease occurring in a patient with multiple myeloma after autologous stem cell transplant

R. Emmons, T. Klumpp, Manish Sharma, 2012, American journal of hematology.

Mobilization of peripheral blood stem cells by subcutaneous injections of yeast‐derived granulocyte macrophage colony stimulating factor: A phase I‐II study

S. Goldberg, T. Klumpp, John Macdonald, 1993, Stem cells.

Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies.

M. Norkin, W. Wood, M. Aljurf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry.

J. Vose, M. Horowitz, R. Gale, 2004, Blood.

Outcomes of two-step haploidentical allogeneic stem cell transplantation in elderly patients with hematologic malignancies

P. Porcu, N. Flomenberg, U. Gergis, 2022, Bone Marrow Transplantation.

A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation.

J. Gajewski, T. Klumpp, A. Sayegh, 2008, Blood.

R-CHOP for mantle cell lymphoma.

T. Klumpp, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD‐based meta‐analysis of cohort studies

J. Mehta, K. Matsuo, J. Kanda, 2009, Transfusion.

Use of ibritumomab tiuxetan anti-CD20 radioimmunotherapy in a non-Hodgkin's lymphoma patient previously treated with a yttrium-90-labeled anti-CD22 monoclonal antibody.

A. Alavi, D. Porter, D. Goldenberg, 2003, Clinical lymphoma.

Outcomes of two-step haploidentical allogeneic stem cell transplantation in elderly patients with hematologic malignancies

P. Porcu, N. Flomenberg, U. Gergis, 2022, Bone Marrow Transplantation.

Serum protein electrophoresis abnormalities in adult solid organ transplant patients with post‐transplant lymphoproliferative disorder *

D. Porter, K. Olthoff, R. Bloom, 2005, Clinical transplantation.

HLA DR15 antigen status does not impact graft-versus-host disease or survival in HLA-matched sibling transplantation for hematologic malignancies.

M. Aljurf, B. George, M. Flowers, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A Prospective, Randomized Trial Examining the Use of G-CSF versus No G-CSF in Patients Post-Autologous Transplant.

P. Porcu, N. Flomenberg, M. Kasner, 2022, Transplantation and cellular therapy.

Economic consequences of alterations in platelet transfusion dose: analysis of a prospective, randomized, double‐blind trial

J. Gaughan, J. Herman, G. Bleecker, 2000, Transfusion.

progenitor cell transplantation A review of transfusion practice before, during, and after hematopoietic

J. Gajewski, T. Klumpp, A. Sayegh, 2008 .

Electronic Medical Records and Quality of Cancer Care

Thomas R. Klumpp, T. Klumpp, 2013, Current Oncology Reports.

Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia

J. Klein, M. Horowitz, J. Wingard, 2014, Clinical Cancer Research.

Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.

Tao Wang, Thomas Spitzer, Daniel J Weisdorf, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis.

J. Dipersio, M. Tallman, R. Gale, 2010, Blood.

Immune‐Mediated Cytopenia following Bone Marrow Transplantation Case Reports and Review of the Literature

M. Caligiuri, J. Ritz, R. Soiffer, 1992, Medicine.

Lack of effect of donor–recipient ABO mismatching on outcome following allogeneic hematopoietic stem cell transplantation

J. Ulicny, R. Emmons, J. Herman, 2006, Bone Marrow Transplantation.

ABO blood group barrier in allogeneic bone marrow transplantation revisited.

A. Barrett, M. Horowitz, R. Gale, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study.

Alan M. Miller, P. D. Dal Cin, J. Sierra, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Autoimmune thrombocytopenia after autologous bone marrow transplantation

J. Herman, T. Klumpp, 1995, American journal of hematology/oncology.

Autoimmune neutropenia following peripheral blood stem cell transplantation

J. Herman, J. Macdonald, T. Klumpp, 1992, American journal of hematology.

AUTOIMMUNE PANCYTOPENIA FOLLOWING BONE MARROW TRANSPLANTATION

T. Klumpp, 1992, British journal of haematology.

Older patients with myeloma derive similar benefit from autologous transplantation.

A. Krishnan, S. Lonial, P. Hari, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Worsening Autoimmune Neutropenia After Stopping Ibrutinib in a Patient With Chronic Lymphocytic Leukemia: Case Report and Review of Literature

S. Gaballa, T. Klumpp, Ba Natalie Rosen, 2019, The Medicine Forum.

Autologous Stem Cell Transplantation for Multiple Myeloma: Growth Factor Matters.

P. Porcu, M. Kasner, T. Klumpp, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Higher rates of relapse in maternal recipients of haploidentical hematopoietic stem cell transplantation from adult offspring donors for AML and myelodysplastic syndrome

B. Leiby, P. Porcu, U. Martinez-outschoorn, 2017, Bone Marrow Transplantation.

Outcome of lower-intensity allogeneic transplantation in non-Hodgkin lymphoma after autologous transplantation failure.

Alan M. Miller, J. Vose, Sonali M. Smith, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Mixed chimerism and graft failure following conditioning with the fludarabine and cyclophosphamide nonablative regimen; Conversion to full donor chimerism

R. Emmons, T. Klumpp, D. Shafer, 2007, American journal of hematology.

Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis.

J. Klein, M. Horowitz, J. Wingard, 2011, Blood.

MYELOABLATIVE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WHO RELAPSE AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION FOR LYMPHOMA: A REPORT OF THE INTERNATIONAL BONE MARROW TRANSPLANT REGISTRY Running head: Allogeneic transplants after autologous failure For Submission to BLOOD, Trans

J. Vose, M. Horowitz, R. Gale, 2004 .

Severe cutaneous ulceration following treatment with thalidomide for GVHD

P. Sabol, T. Klumpp, K. Mangan, 2001, Bone Marrow Transplantation.

The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission.

J. Szer, B. George, M. Tallman, 2010, Blood.

Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort.

J. Klein, M. Horowitz, J. Wingard, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

J. Sierra, M. Tallman, R. Gale, 2008, Blood.

Case Report: Concomitant Diagnosis of Plasma Cell Leukemia in Patient With JAK2 Positive Myeloproliferative Neoplasm

A. Binder, Colin Thomas, T. Klumpp, 2020, Frontiers in Oncology.

Low Non-Relapse Mortality after HLA Matched Related Two-Step Hematopoietic Stem Cell Transplantation using Cyclophosphamide (CY) for Graft versus Host Disease Prophylaxis and the Potential Impact of Non-CY-Exposed T Cells on Outcomes.

P. Porcu, U. Martinez-outschoorn, N. Flomenberg, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

lymphoblastic leukemia in first complete remission Unrelated donor transplants in adults with Philadelphia-negative acute

J. Sierra, R. Gale, M. Bishop, 2011 .

Relationships of physical activity with metabolic syndrome features and low-grade inflammation in adolescents

A. Wagner, B. Schweitzer, C. Platat, 2006, Diabetologia.

Hematopoietic reconstitution by transplantation of stem cells from bone marrow or blood.

T. Klumpp, 2001, New England Journal of Medicine.

Lack of effect of donor‐recipient Rh mismatch on outcomes after allogeneic hematopoietic stem cell transplantation

J. Ulicny, R. Emmons, B. Wirk, 2007, Transfusion.

Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques.

N. Davidson, M. Tallman, L. Akard, 1993, Blood.

Using PROC GENMOD to Model Adverse Event Counts in a Health Care Setting

J. Ulicny, T. Klumpp, 2006 .

The erythroid leukemias: a comparative study of erythroleukemia (FAB M6) and Di Guglielmo disease.

G. Dewald, S. Goldberg, P. Noel, 1998, American journal of clinical oncology.

Identifying Refractory AML Patients Using Rate of WBC Decline in Order to Reduce Length of Stay

T. Klumpp, Kyle Itri, 2019 .

Cell Therapy Informatics: Updates on the integration of HCT/IEC functionalities into an electronic medical record system in the US to promote efficiency, patient safety, research, and data interoperability.

Wayne H. Liang, John Huber, S. Jaglowski, 2023, Transplantation and cellular therapy.

Design and Implementation of a Multipurpose Information System for Hematopoietic Stem-Cell Transplantation on the Basis of the Biomedical Research Integrated Domain Group Model.

P. Porcu, N. Flomenberg, C. McNair, 2021, JCO Clinical Cancer Informatics.

Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort.

M. Horowitz, J. Wingard, R. Gale, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Chronic Graft-Versus-Host Disease Risk Score: A CIBMTR Analysis

M. Horowitz, J. Wingard, R. Gale, 2010 .